Regulation of gene expression by PRA-910, a novel progesterone receptor modulator, in T47D cells

Steroids

Volumn 68, Issue 10-13, 2003, Pages 995-1003

  Bray, Jeffrey D ^a   Zhang, Zhiming ^a   Winneker, Richard C ^a   Lyttle, C Richard ^a  

^a PFIZER INC   (United States)

Author keywords

Affymetrix GeneChip ; PRA 910; Progesterone; Progesterone receptor; Progesterone receptor modulator; Steroid

Indexed keywords

MIFEPRISTONE; P4; PRA 910; PROGESTERONE; PROGESTERONE RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ANALYTIC METHOD; BREAST CANCER; CANCER CELL; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

TRIXIS;

EID: 0345735761     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(03)00119-3     Document Type: Conference Paper

References (29)

1. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H.et al. Two distinct estrogen-regulated promoters generate transcripts encoding two functionally different human progesterone receptor forms A and B. EMBO J. 9:1990;1603-1614.
2. Lydon J.P., DeMayo F.J., Funk C.R., Mani S.K., Hughes A.R., Montgomery C.A. Jr.et al. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Dev. 9:1995;2266-2278.
3. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science. 289:2000;1751-1754.
4. Conneely O.M., Jericevic B.M. Progesterone regulation of reproductive function through functionally distinct progesterone receptor isoforms. Rev. Endocr. Metab. Disord. 3:2002;201-209.
5. Conneely O.M., Mulac-Jericevic B., DeMayo F., Lydon J.P., O'Malley B.W. Reproductive functions of progesterone receptors. Recent Prog. Horm. Res. 57:2002;339-355.
6. Zhang P., Terefenko E.A., Fensome A., Wrobel J., Winneker R., Lundeen S.et al. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists. J. Med. Chem. 45:2002;4379-4382.
7. Zhang Z., Lundeen S.G., Zhu Y., Carver J.M., Winneker R.C. In vitro characterization of trimegestone: a potent and selective progestin. Steroids. 65:2000;637-643.
8. Lundeen S.G., Zhang Z., Zhu Y., Carver J.M., Winneker R.C. Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone. J. Steroid Biochem. Mol. Biol. 78:2001;137-143.
9. Zhang Z, Zhu Y, Rudnick K, Lundeen S, Slayden O, Zhang P, et al. Identification and characterization of a novel nonsteroidal, species-specific progesterone receptor modulator PRA-910. In: Poster presented at the 84th Endocrine Society Meeting, 2002.
10. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J. Biol. Chem. 277:2002;5209-5218.
11. Di Lorenzo D., Albertini A., Zava D. Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D. Cancer Res. 51:1991;4470-4475.
12. Di Lorenzo D., Gianni M., Savoldi G.F., Ferrari F., Albertini A., Garattini E. Progesterone induced expression of alkaline phosphatase is associated with a secretory phenotype in T47D breast cancer cells. Biochem. Biophys. Res. Commun. 192:1993;1077-1082.
13. Kester H.A., van der Leede B.M., van der Saag P.T., van der Burg B. Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J. Biol. Chem. 272:1997;16637-16643.
14. Morita K., Furuse M., Fujimoto K., Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. U.S.A. 96:1999;511-516.
15. Tsukida S., Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J. Cell Biol. 149:2000;13-16.
16. Bause E., Bieberich E., Rolfs A., Volker C., Schmidt B. Molecular cloning and primary structure of Man9-mannosidase from human kidney. Eur. J. Biochem. 217:1993;535-540.
17. Cockcroft S. Phosphatidylinositol transfer proteins: a requirement in signal transduction and vesicle traffic. BioEssays. 20:1998;423-432.
18. Takimoto G.S., Tasset D.M., Eppert A.C., Horwitz K.B. Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3050-3054.
19. Meyer M.E., Quirin-Stricker C., Lerouge T., Bocquel M.T., Gronemeyer H. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 267:1992;10882-10887.
20. Tung L., Mohamed M.K., Hoeffler J.P., Takimoto G.S., Horwitz K.B. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol. 7:1993;1256-1265.
21. Vegeto E., Shabaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7:1993;1244-1255.
22. Sartorius C.A., Tung L., Takimoto G.S., Horwitz K.B. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J. Biol. Chem. 268:1993;9262-9266.
23. McDonnell D.P., Shahbaz M.M., Vegeto E., Goldman M.E. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J. Steroid Biochem. Mol. Biol. 48:1994;425-432.
24. Hovland A.R., Powell R.L., Takimoto G.S., Tung L., Horwitz K.B. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J. Biol. Chem. 273:1998;5455-5560.
25. Spitz I., Chwalisz K. Progesterone receptor modulators and progesterone antagonists in women's health. Steroids. 65:2000;807-815.
26. Lui Z., Auboeuf D., Wong J., Chen J.D., Tsai S.Y., Tsai M.J.et al. Coactivator/corepressor ratios modulate PR-mediated transcription by selective receptor modulator RU486. Proc. Natl. Acad. Sci. U.S.A. 99:2002;7940-7944.
27. Smith C.L., Nawaz Z., O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:1997;657-666.
28. Shang Y., Brown M. Molecular determinants for the tissue specificity of SERMs. Science. 295:2002;2465-2468.
29. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P.et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24:2000;227-235.